The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain

Several novel interleukin (IL)‐10‐related cytokines have recently been discovered. These include IL‐22, IL‐26, and the interferon‐λ (IFN‐λ) proteins IFN‐λ1 (IL‐29), IFN‐λ2 (IL‐28A), and IFN‐λ3 (IL‐28B). The ligand‐binding chains for IL‐22, IL‐26, and IFN‐λ are distinct from that used by IL‐10; however, all of these cytokines use a common second chain, IL‐10 receptor‐2 (IL‐10R2; CRF2‐4), to assemble their active receptor complexes. Thus, IL‐10R2 is a shared component in at least four distinct class II cytokine‐receptor complexes. IL‐10 binds to IL‐10R1; IL‐22 binds to IL‐22R1; IL‐26 binds to IL‐20R1; and IFN‐λ binds to IFN‐λR1 (also known as IL‐28R). The binding of these ligands to their respective R1 chains induces a conformational change that enables IL‐10R2 to interact with the newly formed ligand‐receptor complexes. This in turn activates a signal‐transduction cascade that results in rapid activation of several transcription factors, particularly signal transducer and activator of transcription (STAT)3 and to a lesser degree, STAT1. Activation by IL‐10, IL‐22, IL‐26, or IFN‐λ can be blocked with neutralizing antibodies to the IL‐10R2 chain. Although IL‐10R2 is broadly expressed on a wide variety of tissues, only a subset of these tissues expresses the ligand‐binding R1 chains. The receptors for these cytokines are often present on cell lines derived from various tumors, including liver, colorectal, and pancreatic carcinomas. Consequently, the receptors for these cytokines may provide novel targets for inhibiting the growth of certain types of cancer.

[1]  H. Dickensheets,et al.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[2]  S. Pestka,et al.  Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.

[3]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.

[4]  P. Linsley,et al.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. , 1993, Journal of immunology.

[5]  R. de Waal Malefyt,et al.  Expression cloning and characterization of a human IL-10 receptor. , 1994, Journal of immunology.

[6]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[7]  S. Kotenko,et al.  Interleukin 24 ( MDA-7 / MOB-5 ) Signals through Two Heterodimeric Receptors , IL-22 R 1 / IL-20 R 2 and IL-20 R 1 / IL-20 R 2 * , 2002 .

[8]  D. Lejeune,et al.  Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22 , 2001, The Journal of Immunology.

[9]  K. Asadullah,et al.  A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta , 2001, Genes and Immunity.

[10]  T. Mcclanahan,et al.  Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. , 2004, International immunopharmacology.

[11]  Zemin Zhang,et al.  Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.

[12]  D. Pennica,et al.  CRF2-4: isolation of cDNA clones encoding the human and mouse proteins. , 1997, Gene.

[13]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[14]  J. Darnell,et al.  Stat3 Recruitment by Two Distinct Ligand-induced, Tyrosine-phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain* , 1996, The Journal of Biological Chemistry.

[15]  M. Grace,et al.  Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.

[16]  L. Crepaldi,et al.  Upregulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10 , 2001 .

[17]  M. Rodríguez-Arnao,et al.  Undetectable levels of tumor necrosis factor-alpha, nitric oxide and inadequate expression of inducible nitric oxide synthase in congenital hypothyroidism. , 2003, European cytokine network.

[18]  D. Lejeune,et al.  Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.

[19]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[20]  H. Dickensheets,et al.  Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .

[21]  A. Wlodawer,et al.  Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. , 2003, Biochemistry.

[22]  R. de Waal Malefyt,et al.  Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. , 1993, Journal of immunology.

[23]  Persephone Borrow,et al.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.

[24]  S. Kotenko,et al.  Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.

[25]  S. Kotenko.  The family of IL-10-related cytokines and their receptors: related, but to what extent? , 2002, Cytokine & growth factor reviews.

[26]  G. Lutfalla,et al.  A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR. , 1993, Genomics.

[27]  H. Fickenscher,et al.  Induction of a Novel Cellular Homolog of Interleukin-10, AK155, by Transformation of T Lymphocytes with Herpesvirus Saimiri , 2000, Journal of Virology.

[28]  G. Tosato,et al.  IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. , 1993, International immunology.

[29]  Y. Liu,et al.  A receptor for interleukin 10 is related to interferon receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Karen E. Johnson,et al.  Interleukin 10 (IL-10) and Viral IL-10 Strongly Reduce Antigen-specific Human T Cell Proliferation by Diminishing the Antigen-presenting Capacity of Monocytes via Dowm'egulation of Class H Major Histocompatibility Complex Expression By Ren6 de Waal Malefyt, John Haanen, Hergen Spits, , 1991 .

[31]  K. Asadullah,et al.  Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.

[32]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[33]  K. Winestock,et al.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.

[34]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[35]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[36]  B. Foxwell,et al.  Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages , 2004, The Journal of Immunology.

[37]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[38]  J. Renauld,et al.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Finan,et al.  IL‐10 expression profiling in human monocytes , 2002, Journal of leukocyte biology.

[40]  E. Shevach,et al.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. , 1992, Journal of immunology.

[41]  Diane Lejeune,et al.  Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line , 2002, The Journal of Biological Chemistry.

[42]  S. Smirnov,et al.  Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.

[43]  E. Fish,et al.  Review: IFN-α/β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry , 2002 .

[44]  G. Tosato,et al.  Human interleukin-10 can directly inhibit T-cell growth. , 1993, Blood.

[45]  E. Coccia,et al.  Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells , 2004, European journal of immunology.

[46]  Scott R. Presnell,et al.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Scott R. Presnell,et al.  IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.

[48]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[49]  J. Banchereau,et al.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Lewis-Antes,et al.  IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex , 2003, Nature Immunology.